moxifloxacin has been researched along with Intraocular Pressure in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 12 (75.00) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Liaboe, C; Samuelson, TW | 1 |
| Ali, A; Imtirat, A; Khalili, S; Mireskandari, K; Tehrani, N; Williams, S | 1 |
| Bakbak, B; Gonul, S | 1 |
| Anuradha, A; Nishath, S; Rashmi, G; Shilpa, R; Vidyadevi, M | 1 |
| Moussa, K; Schallhorn, JM; Shantha, J | 1 |
| Ferreira, KSA; Gaete, MIL; Lira, RPC; Lucena, NP; Mélega, MV; Pereira, IMS | 1 |
| Alves, M; Assis Filho, HL; Cardoso da Silva, I; Cavalcanti Lira, RP; Dias Freire, LM; Ferreira, BG; Leite Arieta, CE; Martini, AAF; Melega, MV; Pedreira Chaves, FR; Reis, RD | 1 |
| Hwang, FS; Kim, J; LeClair, B; Nassiri, S; Pham, M; Rauser, ME; Yoon, E | 1 |
| Abdel-Meguid, AAE; Elmenofy, TMI; Gabr, AF; Nassef, MAEH; Said, MM | 1 |
| Gotou, T; Inoue, Y; Matsuura, K; Odawara, S; Sasaki, S; Suto, C | 1 |
| Matsuura, K | 1 |
| Cherof, AM; Kahook, MY; Seibold, LK; SooHoo, JR | 1 |
| Belani, S; Lane, SS; Masket, S; Osher, RH | 1 |
| Bouffioux, C; Caspers, L; Deflorenne, C; Janssens, X; Koch, P; Willermain, F | 1 |
| Chee, SP | 1 |
| Aslan, BS; Ekinci Koktekir, B | 1 |
5 trial(s) available for moxifloxacin and Intraocular Pressure
| Article | Year |
|---|---|
Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis: Randomized controlled clinical trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Corneal Endothelial Cell Loss; Endophthalmitis; Female; Humans; Incidence; Injections; Intraocular Pressure; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Prospective Studies; Visual Acuity | 2019 |
Comparative Study Between Topical Gatifloxacin 0.5% and Moxifloxacin 0.5% as a Prophylactic Measure Before Intraocular Surgery.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Corynebacterium diphtheriae; Eye Infections, Bacterial; Female; Gatifloxacin; Humans; Intraocular Pressure; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Prospective Studies; Staphylococcus aureus | 2019 |
Safety of intracameral injection of moxifloxacin using total replacement technique (bag and chamber flushing).
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Cornea; Endothelium, Corneal; Female; Fluoroquinolones; Humans; Injections, Intraocular; Intraocular Pressure; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Prospective Studies; Therapeutic Irrigation; Time Factors; Visual Acuity | 2014 |
Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Cell Count; Endophthalmitis; Endothelium, Corneal; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Prospective Studies; Quinolines; Tomography, Optical Coherence; Visual Acuity | 2008 |
Moxifloxacin punctum plug for sustained drug delivery.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Cataract; Cataract Extraction; Conjunctivitis, Bacterial; Delayed-Action Preparations; Double-Blind Method; Drug Delivery Systems; Endpoint Determination; Feasibility Studies; Female; Fluoroquinolones; Humans; Intraocular Pressure; Male; Middle Aged; Moxifloxacin; Postoperative Complications; Prospective Studies; Quinolines; Tears; Time Factors | 2012 |
11 other study(ies) available for moxifloxacin and Intraocular Pressure
| Article | Year |
|---|---|
Acute iris toxicity following bilateral gel stent implantation with mitomycin-C and intracameral moxifloxacin January consultation #1.
Topics: Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Mitomycin; Moxifloxacin; Referral and Consultation; Stents | 2022 |
Safety of intracameral moxifloxacin in the pediatric population: an equivalence study.
Topics: Adolescent; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Child; Child, Preschool; Conjunctiva; Corneal Edema; Corneal Pachymetry; Endophthalmitis; Endothelium, Corneal; Female; Follow-Up Studies; Humans; Infant; Injections, Intraocular; Intraocular Pressure; Lens Implantation, Intraocular; Male; Moxifloxacin; Ophthalmic Solutions; Retrospective Studies; Visual Acuity | 2020 |
Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report.
Topics: Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Iris Diseases; Moxifloxacin; Uveitis, Anterior | 2022 |
Safety of Fixed drug Combination in Post -Operative Cataract Patients, at Tertiary Care Centre - In South India.
Topics: Anti-Bacterial Agents; Cataract Extraction; Dose-Response Relationship, Drug; Drug Combinations; Endophthalmitis; Female; Fluprednisolone; Follow-Up Studies; Glucocorticoids; Humans; Incidence; India; Intraocular Pressure; Male; Moxifloxacin; Ophthalmic Solutions; Postoperative Care; Postoperative Complications; Prospective Studies; Tertiary Care Centers | 2017 |
Blurry Vision and Eye Pain After Pterygium Surgery.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Eye Infections, Bacterial; Eye Pain; Female; Glucocorticoids; Humans; Indomethacin; Intraocular Pressure; Levofloxacin; Moxifloxacin; Ophthalmologic Surgical Procedures; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Pterygium; Scleritis; Vision Disorders; Visual Acuity | 2018 |
Intracameral moxifloxacin after cataract surgery: a prospective study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Endophthalmitis; Female; Fluoroquinolones; Humans; Injections, Intraocular; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Postoperative Complications; Prospective Studies; Reproducibility of Results; Statistics, Nonparametric; Time Factors; Treatment Outcome; Visual Acuity | 2018 |
Comparative analysis of intravitreal triamcinolone acetonide-moxifloxacin versus standard perioperative eyedrops in cataract surgery.
Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Corneal Edema; Drug Combinations; Female; Glucocorticoids; Humans; Inflammation; Intraocular Pressure; Intravitreal Injections; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Retrospective Studies; Triamcinolone Acetonide | 2019 |
Long-term effects of intracameral moxifloxacin.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Endothelium, Corneal; Female; Fluoroquinolones; Follow-Up Studies; Fovea Centralis; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Male; Moxifloxacin; Visual Acuity | 2015 |
Endophthalmitis With Corneal Infiltrate After EX-PRESS Glaucoma Drainage Device Implantation.
Topics: Alkylating Agents; Anti-Bacterial Agents; Corneal Diseases; Device Removal; Drug Combinations; Endophthalmitis; Fluoroquinolones; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Moxifloxacin; Prednisolone | 2016 |
Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Eye Diseases; Fluoroquinolones; Humans; Intraocular Pressure; Iris; Laser Coagulation; Male; Moxifloxacin; Pigmentation Disorders; Quinolines; Transillumination; Treatment Outcome; Uveitis, Anterior | 2010 |
Safety of prophylactic intracameral moxifloxacin use in cataract surgery.
Topics: Aged; Aza Compounds; Cataract; Cataract Extraction; Cornea; Endophthalmitis; Female; Fluoroquinolones; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Post-Exposure Prophylaxis; Quinolines; Retina; Tomography, Optical Coherence; Visual Acuity | 2012 |